[^1]
| Protein Name | BACH1 |
| Gene | [BACH1](/genes/bach1) |
| UniProt | O14867 |
| PDB | 2IHC |
| Mass | 82.4 kDa (736 amino acids) |
| Family | CNC-bZIP transcription factor family |
| Diseases | [Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/als) |
| Localization | Nucleus (repressive), Cytoplasm (heme-bound, degraded) |
BACH1 (BTB and CNC Homolog 1) is a transcriptional repressor that functions as the primary antagonist of NRF2 at antioxidant response elements (AREs). BACH1 acts as a cellular heme sensor — under basal conditions, BACH1 occupies AREs and represses cytoprotective gene expression. When heme levels rise during oxidative stress, heme binds BACH1's cysteine-proline (CP) motifs, triggering nuclear export and proteasomal degradation. This derepression allows NRF2 to activate HMOX1, NQO1, glutathione synthesis enzymes, and other antioxidant genes.
In neurodegenerative diseases, impaired BACH1 degradation contributes to inadequate antioxidant responses, making BACH1 an emerging therapeutic target for neuroprotection.
¶ Domain Architecture
BACH1 is a 736-amino acid protein with distinct functional domains:
- BTB/POZ domain (residues 1-128): Broad-complex, Tramtrack, Bric-à-brac domain mediating homodimerization and transcriptional repression; recruits corepressor complexes (NCoR, SMRT)
- CNC-bZIP domain (residues 558-625): Cap'n'collar basic leucine zipper domain for DNA binding; heterodimerizes with small Maf proteins (MafF, MafG, MafK)
- CP motifs (6 total): Cysteine-Proline heme-binding motifs distributed throughout the protein (CP1-CP6); heme binding at CP3-CP6 triggers nuclear export
- Cytoplasmic localization signal (CLS, residues 331-435): NES-containing region that mediates CRM1-dependent nuclear export upon heme binding
- Nuclear localization signal (NLS): Ensures nuclear import under basal conditions
BACH1 contains six CP motifs, four of which (CP3, CP4, CP5, CP6) bind heme with physiologically relevant affinity:
- Heme Fe2+ coordinates with the cysteine thiolate of CP motifs
- Heme binding induces conformational change that exposes the CLS/NES
- Kd for heme binding: ~0.1-1 µM (within the range of intracellular labile heme pool)
- The BTB domain is not affected by heme binding, maintaining BACH1's capacity for protein-protein interactions
Under basal (non-stressed) conditions:
- BACH1 heterodimerizes with small Maf proteins in the nucleus
- BACH1-Maf complexes bind to MAREs/AREs in promoters of target genes
- The BTB domain recruits NCoR/SMRT corepressor complexes and HDACs
- Target genes (HMOX1, FTH1, FTL, SLC40A1, NQO1) are maintained in a repressed state
- This establishes a low basal level of antioxidant gene expression sufficient for housekeeping
Upon oxidative stress or heme accumulation:
- Free heme binds to CP3-CP6 motifs on BACH1
- Heme binding disrupts BACH1-DNA interaction
- CRM1/Exportin-1 recognizes the exposed NES, exporting BACH1 from the nucleus
- Cytoplasmic BACH1 is polyubiquitinated by the HOIL-1/HOIP linear ubiquitin assembly complex and FBXL17
- Ubiquitinated BACH1 is degraded by the 26S proteasome
- AREs are now vacant for NRF2-Maf heterodimer binding
- NRF2 activates transcription of >200 cytoprotective genes
Key BACH1-repressed genes relevant to neurodegeneration:
| Gene |
Protein |
Function |
| HMOX1 |
Heme oxygenase-1 |
Heme degradation, CO/biliverdin production |
| FTH1 |
Ferritin heavy chain |
Iron sequestration |
| FTL |
Ferritin light chain |
Iron storage |
| SLC40A1 |
Ferroportin |
Iron export |
| NQO1 |
NAD(P)H quinone dehydrogenase 1 |
Quinone detoxification |
| GCLC/GCLM |
Glutamate-cysteine ligase |
Glutathione synthesis |
¶ Oxidative Stress and Neuronal Vulnerability
Neurons are exquisitely vulnerable to oxidative damage due to:
- High oxygen consumption (20% of total body O2 for ~2% of body mass)
- Abundant polyunsaturated fatty acids susceptible to lipid peroxidation
- High iron content in substantia nigra and globus pallidus
- Limited antioxidant reserves compared to astrocytes
BACH1 repression of antioxidant genes exacerbates this vulnerability.
In AD:
- BACH1 protein levels are elevated in hippocampal neurons of AD patients, associated with reduced HMOX1 expression
- Amyloid-beta-induced oxidative stress generates heme but may not be sufficient to fully degrade BACH1 in aged neurons
- BACH1 gene is on chromosome 21 — potentially overexpressed in Down syndrome (trisomy 21), which carries near-universal AD risk
- BACH1 knockout mice show enhanced neuroprotection against amyloid-beta toxicity through HMOX1 upregulation
In PD:
- Dopamine metabolism generates reactive quinones and superoxide, requiring robust NRF2 activity
- BACH1 limits HMOX1 expression in substantia nigra dopaminergic neurons, reducing their capacity to handle iron-mediated oxidative stress
- BACH1 inhibition enhances NRF2-mediated protection of dopaminergic neurons in MPTP and 6-OHDA models
- Alpha-synuclein aggregation impairs the KEAP1-NRF2 pathway, making BACH1 derepression even more critical
BACH1 inhibition strategies:
- Heme mimetics: Synthetic metalloporphyrins that bind BACH1 CP motifs
- Direct BACH1-DNA interaction inhibitors: Small molecules disrupting BACH1-ARE binding
- BACH1 degradation enhancers: Compounds promoting FBXL17-mediated ubiquitination
- HMOX1 inducers: Dimethyl fumarate (Tecfidera) partly works via BACH1 pathway
Key protein-protein interactions:
- Small Maf proteins (MafF, MafG, MafK) — DNA-binding partners
- NCoR/SMRT — Corepressor recruitment via BTB domain
- CRM1/Exportin-1 — Nuclear export receptor
- FBXL17 — E3 ubiquitin ligase for BACH1 degradation
- HOIL-1/HOIP — Linear ubiquitin ligase complex